Plendil is an antiarrhythmic drug that is used to treat angina caused by unstable angina when other antianginal drugs, such as nitrates, are intolerant. It is also used to prevent the recurrence of angina attacks. This is a drug that blocks calcium from entering the heart.
Felodipine extended release is aimed at maintaining continued action of the drug after its administration, even if the drug is not potent. The active ingredient in felodipine is felodipinodine hydrochloride, which belongs to the class of calcium channel blockers, and it has properties similar to natural calcium channel blockers.
Indications for use of Plendil include sustained significant elevation of blood pressure, angina (when beta blockers or nitrates are contraindicated or ineffective) and Raynaud's phenomenon (cold skin syndrome).
It can be used during pregnancy if a woman is hospitalized for angina or hypertension, but the use of this medicine is not advisable while breastfeeding as the effect of the medicine on the infant is still unknown.
Contraindications: Plendil should not be taken if the patient has registered allergies.